123 related articles for article (PubMed ID: 30788877)
1. National Cancer Database Analysis of the effect of brachytherapy on overall survival in patients with base of tongue cancer.
Silva SR; Martin B; Choi M; Emami B; Hurst NJ
Head Neck; 2019 May; 41(5):1184-1192. PubMed ID: 30788877
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base.
Amini A; Jones BL; Jackson MW; Rusthoven CG; Maroni P; Kavanagh BD; Raben D
Brachytherapy; 2016; 15(2):136-46. PubMed ID: 26825856
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
5. Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer.
Johnson SB; Lester-Coll NH; Kelly JR; Kann BH; Yu JB; Nath SK
Eur Urol; 2017 Nov; 72(5):738-744. PubMed ID: 28688613
[TBL] [Abstract][Full Text] [Related]
6. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
7. Outcomes with brachytherapy based dose escalation for gleason 8 versus 9-10 prostate cancer: An NCDB analysis.
David J; Luu M; Lu D; Zumsteg ZS; Sandler H; Kamrava M
Urol Oncol; 2021 Dec; 39(12):829.e19-829.e26. PubMed ID: 34049784
[TBL] [Abstract][Full Text] [Related]
8. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
[TBL] [Abstract][Full Text] [Related]
9. The role of radiation therapy in the treatment of Stage II endometrial cancer: A large database study.
Wojcieszynski AP; Hullett CR; Medlin EE; Taunk NK; Shabason JE; Brower JV; Chen S; Bekelman JE; Barroilhet LM; Bradley KA
Brachytherapy; 2018; 17(4):645-652. PubMed ID: 29691149
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer.
Takácsi-Nagy Z; Oberna F; Koltai P; Hitre E; Major T; Fodor J; Polgár C
Brachytherapy; 2013; 12(6):535-41. PubMed ID: 23988507
[TBL] [Abstract][Full Text] [Related]
11. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
Stokes WA; Jones BL; Schefter TE; Fisher CM
Brachytherapy; 2018; 17(1):194-200. PubMed ID: 29097136
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
[TBL] [Abstract][Full Text] [Related]
13. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
[TBL] [Abstract][Full Text] [Related]
14. Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy.
Liu Y; Patel SA; Jani AB; Gillespie TW; Patel PR; Godette KD; Hershatter BW; Shelton JW; McDonald MW
Clin Genitourin Cancer; 2021 Jun; 19(3):255-266.e7. PubMed ID: 32972877
[TBL] [Abstract][Full Text] [Related]
15. Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy.
Gill BS; Chapman BV; Hansen KJ; Sukumvanich P; Beriwal S
Brachytherapy; 2015; 14(3):373-9. PubMed ID: 25600451
[TBL] [Abstract][Full Text] [Related]
16. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
17. Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy.
Yang DD; Muralidhar V; Mahal BA; Nguyen PL; Devlin PM; King MT; Orio PF
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):53-58. PubMed ID: 29254781
[TBL] [Abstract][Full Text] [Related]
18. Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base.
Amini A; Jones B; Jackson MW; Yeh N; Waxweiler TV; Maroni P; Kavanagh BD; Raben D
J Urol; 2016 May; 195(5):1453-1458. PubMed ID: 26576709
[TBL] [Abstract][Full Text] [Related]
19. Survival after radiotherapy vs. radical prostatectomy for unfavorable intermediate-risk prostate cancer.
Sebastian NT; McElroy JP; Martin DD; Sundi D; Diaz DA
Urol Oncol; 2019 Nov; 37(11):813.e11-813.e19. PubMed ID: 31109836
[TBL] [Abstract][Full Text] [Related]
20. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
